Successfully identify and execute strategic partnerships, licensing, and M&A Deals
The BD&L community is dedicated to dealmaking in the life sciences industry, bringing together cross-functional experts from pharma, biotech and VCs to share best practices in due diligence, capital raising and M&A, licensing, and strategic alliance transactions.
Explore the dynamics of partnerships and investments in the life sciences industry, examine the changing landscape of deal structures and innovative licensing models, and gain insights that will unlock the potential of a deal and drive a company’s competitive position in the marketplace.
Registration is FREE for Biotech, Pharma, Investors & Clinical Sites Professionals but only for a Limited Time!
Attend for free
JOIN FIERCE BIOTECH WEEK
Be part of the premier event shaping the future of biotech and pharma.
Qualifying professionals can attend Fierce Biotech Week for free—must work in biotech, pharma, investment, and clinical site roles. Apply now for a FREE VIP Pass.
Key Topics Covered for BD&L
Deal Drivers and Investment Priorities for Big Pharma and VCs
Operating Models for Search and Evaluation to Advance Innovation
IP Due Diligence Issues that can Derail a Deal
Dealmaking Trends and Insights for New Modalities and Technologies
Alternative Deal Constructs and Creative Financing
Negotiating and Evaluating Platform Deals
